Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer

Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1

(2016) Erika Vacchelli et al.   OncoImmunology

Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

(2015) Padmanee Sharma et al.   CELL

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

(2015) E. Vacchelli et al.   SCIENCE

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

(2014) Antonella Sistigu et al.   NATURE MEDICINE

Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy

(2014) Yuting Ma et al.   OncoImmunology

Synergistic antitumor effects of a TGFβ inhibitor and cyclophosphamide

(2014) Xin Chen et al.   OncoImmunology

Immune checkpoints

(2014) Akhil Chawla et al.   OncoImmunology

Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy

(2014) Gautier Stoll et al.   OncoImmunology

Myeloid-derived cells are key targets of tumor immunotherapy

(2014) José Medina-Echeverz et al.   OncoImmunology

Consensus guidelines for the detection of immunogenic cell death

(2014) Oliver Kepp et al.   OncoImmunology

Autophagy and Cellular Immune Responses

(2013) Yuting Ma et al.   IMMUNITY

Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance

(2013) Laurence Zitvogel et al.   IMMUNITY

Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A12-26

(2012) Chengxue Qin et al.   BRITISH JOURNAL OF PHARMACOLOGY

Reporting of preclinical tumor-graft cancer therapeutic studies

(2012) Elizabeth Sugar et al.   CANCER BIOLOGY & THERAPY

An Immunosurveillance Mechanism Controls Cancer Cell Ploidy

(2012) L. Senovilla et al.   SCIENCE

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

Decoding Cell Death Signals in Inflammation and Immunity

(2010) Laurence Zitvogel et al.   CELL

Annexin A1 expression and its prognostic significance in human breast cancer

(2010) L. Wang et al.   NEOPLASMA

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

(2009) François Ghiringhelli et al.   NATURE MEDICINE

The anticancer immune response: indispensable for therapeutic success?

(2008) Laurence Zitvogel et al.   JOURNAL OF CLINICAL INVESTIGATION

Loss of Annexin A1 Expression in Breast Cancer Progression

(2008) Ying Cao et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY